Expression and function of B7-1 and B7-2 in hapten-induced contact sensitivity (Q28565173)

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

B70 antigen is a second ligand for CTLA-4 and CD28.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

Expression and function of the costimulatory molecule B7 on murine Langerhans cells: evidence for an alternative CTLA-4 ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

Comparative analysis of B7-1 and B7-2 expression in Langerhans cells: differential regulation by T helper type 1 and T helper type 2 cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

Murine B7 antigen provides an efficient costimulatory signal for activation of murine T lymphocytes via the T-cell receptor/CD3 complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

Identification of an alternative CTLA-4 ligand costimulatory for T cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

Treatment of murine lupus with CTLA4Ig

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

CTLA4Ig treatment ameliorates the lethality of murine graft-versus-host disease across major histocompatibility complex barriers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260424

7 January 2021